Fingerprint
Dive into the research topics of 'A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Opthea Study Group Investigators
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations